Accelerate Diagnostics Inc Aktien im Umlauf
Was ist das Aktien im Umlauf von Accelerate Diagnostics Inc?
Aktien im Umlauf von Accelerate Diagnostics Inc ist 23.679M
Was ist die Definition von Aktien im Umlauf?
Im Umlauf befindliche Aktien sind alle Aktien einer Gesellschaft oder eines finanziellen Vermögenswertes, die von Anlegern genehmigt, ausgegeben und gekauft wurden und von diesen gehalten werden.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Aktien im Umlauf von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Accelerate Diagnostics Inc
Was macht Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Unternehmen mit aktien im umlauf ähnlich Accelerate Diagnostics Inc
- ArcBest Corp hat Aktien im Umlauf von 23.646M
- RPP Infra Projects hat Aktien im Umlauf von 23.651M
- Colorado Resources hat Aktien im Umlauf von 23.651M
- Trecora Resources hat Aktien im Umlauf von 23.651M
- Outlook Therapeutics Inc hat Aktien im Umlauf von 23.656M
- 1300SMILES hat Aktien im Umlauf von 23.678M
- Accelerate Diagnostics Inc hat Aktien im Umlauf von 23.679M
- Ceva hat Aktien im Umlauf von 23.686M
- Gravitas Ii Capital Corp hat Aktien im Umlauf von 23.688M
- Encore Capital hat Aktien im Umlauf von 23.691M
- Inogen Inc hat Aktien im Umlauf von 23.719M
- Rice Acquisition hat Aktien im Umlauf von 23.728M
- Blue Dart Express hat Aktien im Umlauf von 23.728M